Ledger.Open graph →
SEC Form D · filed September 21, 2018

VistaGen Therapeutics, Inc

Offering
$5.8M
Sold
$4.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
South San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Earl Webb · Chicago, ILExecTyler Tringas · Miami, FLDirectorMark W. Brooker · Houston, TXDirectorAsia Capital Management, L.P · Grand Cayman, Cayman IslandsExec · DirectorMark Rose · Chicago, ILExec · DirectorJoon H. Hwang · Seoul, M5DirectorYanghee Paik · Buena Park, CAExecBarrett R. Sigmund · Seattle, WAExecIshaan Nerurkar · Berkeley, CADirectorMichael Theilmann · Berkeley, CAExec · DirectorColton Jang · Berkeley, CAExecPaul G. Roess · Chattanooga, TNExec · DirectorMark W. Piper · SEATTLE, WAExecScott Gazelle · Richmond, VADirectorSteve Wallace · Richmond, VAExecDonna Edmonds · Richmond, VADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗